General
Preferred name
IPRIFLAVONE
Synonyms
7-(1-Methyethoxy)-3-phenyl-4h-1-benzopyran-4-one ()
Osteofix ()
Osten ()
Ipriflavone (Osteofix) ()
Ostivone ()
Ipriflavona ()
NSC-755888 ()
7-isopropoxyisoflavone ()
P&D ID
PD002503
CAS
35212-22-7
Tags
available
drug
Drug indication
Osteoporosis
Drug Status
experimental
investigational
approved
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
1
Organisms
2
Compound Sets
19
Cayman Chemical Bioactives
26319
ChEMBL Drugs
CHEMBL165790
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DB13618
DrugCentral
1477
DrugCentral Approved Drugs
1477
DrugMAP
DM0IO13
DrugMAP Approved Drugs
DM0IO13
DrugMatrix
MedChem Express Bioactive Compound Library
HY-N0094
Natural product-based probes and drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
ipriflavone
TargetMol Bioactive Compound Library
T0309
The Spectrum Collection
External IDs
33
Properties
(calculated by RDKit )
Molecular Weight
280.11
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
3
cLogP
4.25
TPSA
39.44
Fraction CSP3
0.17
Chiral centers
0.0
Largest ring
6.0
QED
0.72
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
advanced glycation end products
Cytochrome P450
Indication
osteoporosis
MOA
bone resorption inhibitor
Biosynthetic Origin
Polyketide (Flavonoid)
Therapeutic Indication
Calcium Metabolism
Therapeutic Class
Hormone Therapy
Pathway
Metabolic Enzyme/Protease
Source data